You are here

  • Home
  • Archive
  • Volume 81, Issue 6
  • Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial

Article metrics

Article menu
Download PDFPDF
Epidemiology
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial

 

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

AbstractFullPdf
Feb 202215631593327
Mar 202215721530502
Apr 2022721720190
May 2022768760177
Jun 2022548554178
Jul 2022539534137
Aug 2022305296109
Sep 202223123091
Oct 202228027898
Nov 202218217679
Dec 202213212885
Jan 202313312456
Feb 202313613062
Mar 202318816663
Apr 20234123820
May 20234592919
Jun 20232771312
Jul 2023230119
Aug 202320242
Sep 20232792017
Oct 20232451918
Nov 2023290189
Dec 202316856
Jan 2024169116
Feb 2024219159
Mar 2024361135
Total1060974152286